ИЗУЧЕНИЕ ДОЛГОЖИТЕЛЬСТВА: СОВРЕМЕННЫЙ СТАТУС ПРОБЛЕМЫ И ПЕРСПЕКТИВЫ. ЧАСТЬ 1

Увеличение продолжительности жизни определяет  стремительный рост  числа  людей  пожилого и старческого  возрастов.  Различия между хронологическим и биологическим возрастом,  между скоростью старения разных людей дают основания для изучения биологических и  генетических  факторов  долгожительства.  В серии обзорных  статей  суммированы  результаты  исследований  в этих областях.  Однако помимо  фундаментального  научного интереса общее   старение   населения   и  долгожительство  тесно  связаны с медико-социальными вопросами организации гериатрической помощи. Несмотря на высокий интерес, долгожительство остается во   многом   недостаточно   изученным   и   понятным  явлением. Представленный обзор охватывает широкий спектр изучения проблем долгожительства — от генетических исследований до медикосоциальных проблем.

1. Goldman DP, Cutler D, Rowe JW, et al. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 2013; 32(10): 1698-705.

2. Martin GM. Genetic modulation of senescent phenotypes in Homo sapiens. Cell 2005; 120(4): 523-32.

3. Andersen SL, Sebastiani P, Dworkis DA, et al. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci 2012; 67(4): 395-405.

4. Sebastiani P, Sun FX, Andersen SL, et al. Families Enriched for Exceptional Longevity also have Increased Health-Span: Findings from the Long Life Family Study. Front Public Health 2013; 1: 38.

5. Evans CJ, Ho Y, Daveson BA, et al. Place and cause of death in centenarians: a population-based observational study in England, 2001 to 2010. PLoS Med 2014; 11(6): e1001653.

6. Ailshire JA, Beltran-Sanchez HEM. Crimmins, Becoming centenarians: disease and functioning trajectories of older US Adults as they survive to 100. J Gerontol A Biol Sci Med Sci 2015; 70(2): 193-201.

7. Pushkova ES, Lenskaya LV. Longevity in Saint-Petersburg. Biomeditsinskiy Journal 2003; 4(29): 32-4. Russian (Пушкова Э. С., ленская л. В., долгожительство в Санкт-Петербурге. Биомедицинский журнал 2003; 4(29): 32-4).

8. Shabalin AV, Voevoda MI, Chernih NI, et al. Longevity — the model for study of ageing. Bulletin of SB RAMS 2006; 4(122): 11-21. Russian (Шабалин а. В., Воевода М. и., черных Н. и. и др. долгожительство — модель изучения процесса старения. Бюллетень СО РаМН 2006; 4(122): 11-21).

9. Denisova TP, Malinova LI, Cherevatova OM, et al. Age-dependent dynamics of screening metabolic parameters in long-livers and its biophysical estimation. Saratov Journal of Medical Scientific Research 2015; 11(1): 28-31. Russian (денисова т. П., Малинова л. и., череватова О. М. Возраст-зависимая динамика скрининговых метаболических параметров у долгожителей и ее биофизическая оценка. Саратовский научно-медицинский журнал 2015; 11(1): 28-31).

10. Schoenmaker M, de Craen AJ, de Meijer PH, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 2006; 14(1): 79-84.

11. Westendorp RG, van Heemst D, Rozing MP, et al. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc 2009; 57(9): 1634-7.

12. Perls TT, Wilmoth J, Levenson R, et al. Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A 2002; 99(12): 8442-7.

13. Atzmon G, Schechter C, Greiner W, et al. Clinical phenotype of families with longevity. J Am Geriatr Soc 2004; 52(2): 274-7.

14. Adams ER, Nolan VG, Andersen SL, et al. Centenarian offspring: start healthier and stay healthier. J Am Geriatr Soc 2008; 56(11): 2089-92.

15. Altmann-Schneider I, van der Grond J, Slagboom PE, et al. Lower susceptibility to cerebral small vessel disease in human familial longevity: the Leiden Longevity Study. Stroke 2013; 44(1): 9-14.

16. Lipton RB, Hirsch J, Katz MJ, et al, Exceptional parental longevity associated with lower risk of Alzheimer’s disease and memory decline. J Am Geriatr Soc 2010; 58(6): 1043-9.

17. Florez H, Ma Y, Crandall JP, et al. Parental longevity and diabetes risk in the Diabetes Prevention Program. J Gerontol A Biol Sci Med Sci 2011; 66(11): 1211-7.

18. Rajpathak SN, Liu Y, Ben-David O, et al. Lifestyle factors of people with exceptional longevity. J Am Geriatr Soc 2011; 59(8): 1509-12.

19. Beekman M, Nederstigt C, Suchiman HE, et al. Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. Proc Natl Acad Sci U S A 2010; 107(42): 18046-9.

20. Sebastiani P, Solovieff N, Dewan AT, et al. Genetic signatures of exceptional longevity in humans. PLoS One 2012; 7(1): e29848.

21. Nebel A, Kleindorp R, Caliebe A, et al. A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev 2011; 132(6-7): 324-30.

22. Milman S, Barzilai N. Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span. Cold Spring Harb Perspect Med 2015; 6(1): a025098.

23. Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 2008; 63(5): 447-53.

24. Atzmon G, Barzilai N, Surks MI, et al. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab 2009; 94(12): 4768-75.

25. Atzmon G, Cho M, Cawthon RM, et al. Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci U S A 2010; 107 Suppl 1: 1710-7.

26. Carmi S, Hui KY, Kochav E, et al. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat Commun 2014; 5: 4835.

27. Freudenberg-Hua Y, Freudenberg J, Vacic V, et al. Disease variants in genomes of 44 centenarians. Mol Genet Genomic Med 2014; 2(5): 438-50.

28. Bonafe M, Marchegiani F, Cardelli M, et al. Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet 2002; 10(5): 292-6.

29. Franceschi C, Olivieri F, Marchegiani F, et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev 2005; 126(2): 351-61.

30. Marchegiani F, Marra M, Spazzafumo L, et al. Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci 2006; 61(6): 541-6.

31. Kojima T, Kamei H, Aizu T, et al. Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways. Exp Gerontol 2004; 39(11-12): 1595-8.

32. van Heemst D, Beekman M, Mooijaart SP, et al. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005; 4(2): 79-85.

33. Mecocci P, Polidori MC, Troiano L, et al. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic Biol Med 2000; 28(8): 1243-8.

34. Barzilai N, Atzmon G, Derby CA, et al. A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology 2006; 67(12): 2170-5.

35. Kahn AJ. FOXO3 and related transcription factors in development, aging, and exceptional longevity. J Gerontol A Biol Sci Med Sci 2015; 70(4): 421-5.

36. Monsalve M, Olmos Y. The complex biology of FOXO. Curr Drug Targets 2011; 12(9):1322-50.

37. Lawrence RW, Evans DM, Cardon LR. Prospects and pitfalls in whole genome association studies. Philos Trans R Soc Lond B Biol Sci 2005; 360(1460): 1589-95.

38. Barzilai N, Gabriely I, Gabriely M, et al. Offspring of centenarians have a favorable lipid profile. J Am Geriatr Soc 2001; 49(1): 76-9.